Spectrum Pharmaceuticals, Inc.SPPINASDAQ
Loading
EBITDA Over TimeExpanding
Percentile Rank40
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-65.46M
↑ 21% vs avg
Percentile
P40
Within normal range
Streak
3 yr
Consecutive growthExpanding
Average
$-82.62M
Historical baseline
PeriodValueYoY Change
TTM$-65.46M+15.0%
2022$-77.06M+47.7%
2021$-147.42M+13.0%
2020$-169.47M-9.6%
2019$-154.59M-65.3%
2018$-93.50M-36.2%
2017$-68.62M-97.2%
2016$-34.80M-850.2%
2015$-3.66M+68.6%
2014$-11.65M-